Haemodynamic and Electrophysiologic Effects of Diltiazem
- 1 August 1985
- journal article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 57 (s2), 21-30
- https://doi.org/10.1111/j.1600-0773.1985.tb03571.x
Abstract
This review describes the haemodynamic and electrophysiologic properties of diltiazem and shows how these effects may, in some clinical situations, favour the choice of this drug as an antianginal and antiarrhythmic agent. Compared to nifedipine and verapamil, diltiazem has the distinct advantage of being a negative chronotropic agent and thus has the potential of leading to a greater reduction in myocardial oxygen consumption; it does not affect cardiac output, left ventricular end diastolic pressure, and ejection fraction in patients with an adequately preserved left ventricular function; finally, it possesses a longer duration of action and fewer side effects, even at relatively high calcium entry blocking doses, than the other major calcium entry blockers.Keywords
This publication has 10 references indexed in Scilit:
- Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: Comparison at 1, 3 and 8 hours and correlation with plasma drug concentrationThe American Journal of Cardiology, 1984
- Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias.Circulation, 1983
- Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: A reviewThe American Journal of Cardiology, 1982
- Increased exercise tolerance and reduced electrocardiographic ischemia with diltiazem in patients with stable angina pectoris.Circulation, 1982
- Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.Circulation, 1981
- Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazemThe American Journal of Cardiology, 1980
- Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical ApplicationsAnnals of Internal Medicine, 1980
- Hemodynamics and Coronary Flow Following Diltiazem Administration in Anesthetized Dogs and in HumansChest, 1980
- Calcium antagonistsAmerican Heart Journal, 1980
- Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1977